RM

Radheal Manickathan Varghese

Active Director Director DIN 09858170
DIN 09858170 First appointment Jan 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Radheal Manickathan Varghese

Data last updated:

Radheal Manickathan Varghese is a Director at Itea Life Sciences Private Limited (since 2023). The company operates in Chemicals.

DIN 09858170
Primary Designation Director
Industry Chemicals
First Appointment 11 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Itea Life Sciences Private Limited U24290KL2023PTC079931
Director11 Jan 20232023Active

Board colleagues of Radheal Manickathan Varghese

Directorship timeline

Open interactive timeline →
Itea Life Sciences Private Limited
Premium access

Shareholding and investment profile for Radheal Manickathan Varghese

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radheal Manickathan Varghese

Radheal Manickathan Varghese currently holds 1 directorship: Itea Life Sciences Private Limited (Director, since 11 Jan 2023).

Radheal Manickathan Varghese was first appointed on 11 Jan 2023 as Director at Itea Life Sciences Private Limited.

The current boards of Radheal Manickathan Varghese's companies include Baburaj Manchadath Raghavan Menon (Itea Life Sciences Private Limited), Nirmal Bertil (Itea Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available